|
|
|
Volumn 176, Issue 2364, 2002, Pages 4-5
|
|
Cancer scare hits gene cures: a second major setback for medicine's most pioneering treatment has split the scientific community. Could a moratorium do more harm than good?
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ARTICLE;
BIOMEDICAL AND BEHAVIORAL RESEARCH;
COMBINED IMMUNODEFICIENCY;
FRANCE;
GENE THERAPY;
GENETICS AND REPRODUCTION;
GOVERNMENT REGULATION;
HUMAN;
HUMAN EXPERIMENT;
INFANT;
LEGAL APPROACH;
LEGAL ASPECT;
LEUKEMIA;
MALE;
PRESCHOOL CHILD;
RISK ASSESSMENT;
UNITED KINGDOM;
UNITED STATES;
BIOMEDICAL AND BEHAVIORAL RESEARCH;
GENETICS AND REPRODUCTION;
LEGAL APPROACH;
CHILD, PRESCHOOL;
FRANCE;
GENE THERAPY;
GOVERNMENT REGULATION;
GREAT BRITAIN;
HUMAN EXPERIMENTATION;
HUMANS;
INFANT;
LEUKEMIA;
MALE;
RISK ASSESSMENT;
SEVERE COMBINED IMMUNODEFICIENCY;
UNITED STATES;
|
|
EID: 0041385574
PISSN: 02624079
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (4)
|
|
References (0)
|
